Rothman Orthopaedics Institute

Thomas Jefferson University Hospitals was nationally ranked in seven of 14 specialties, and MossRehab (Jefferson Moss Magee Rehabilitation) was ranked in the top 10 for Rehabilitation. PHILADELPHIA, July 16, 2024 /PRNewswire/ -- The U.S. News & World Report released its 2024-2025 annual Best Hospitals rankings and recognized Jefferson Health among the best in the United States. Thomas Jefferson University Hospitals was recognized as second in the nation for Ophthalmology (Wills Eye Hospital), and MossRehab, now Jefferson Moss-Magee Rehabilitation, ranked 8th in the country for Rehabilitation. Continue Reading Thomas Jefferson University Hospitals ranked 2nd in Pennsylvania and remains 2nd in the Philadelphia metro area. Post this Jefferson Health Thomas Jefferson University Hospitals ranked 2nd in Pennsylvania (up from #3 in 2023) and remains 2nd in the Philadelphia metro area. Jefferson Abington Hospital ranked 7th in the Philadelphia region (up from #8 in 2023) and 13th in Pennsylvania (up from #17 in 2023). Jefferson Health New Jersey ranked 8th in New Jersey and 12th in the Philadelphia region (up from #15 in 2023). "These results speak to Jefferson's unwavering dedication to delivering high-quality, culturally competent, and compassionate healthcare. Our commitment to uncompromising care reaches far beyond the walls of individual hospitals; it is the heartbeat of our entire healthcare system. Celebrating our achievements in the latest rankings is just one measure of Jefferson's success. Our focus transcends these rankings, prioritizing quality, innovation, research, and operational rigor," said Baligh Yehia, MD, MPP, MSc, President of Jefferson Health. I express our deepest gratitude to the Jefferson clinicians and support staff for their tireless efforts and heartfelt dedication are crucial to our mission of transforming healthcare and improving lives in our region and beyond." U.S. News & World Report ranked the following Thomas Jefferson University Hospitals specialties among the nation's best: Ophthalmology (2nd) – Wills Eye Hospital Ear, Nose and Throat (20th) – up from #27 in 2023-24 ranking Orthopedics (20th) Rothman Orthopaedics at Jefferson Health and The Philadelphia Hand to Shoulder Center at Jefferson Health – up from #34 in 2023-24 ranking Neurology and Neurosurgery (27th) – up from #40 in 2023-24 ranking Urology (29th) – up from #30 in 2023-24 ranking Gastroenterology and GI Surgery (31st) – same as the 2023-204 ranking Pulmonology and Lung Surgery (39th) – up from #40 in 2023-24 ranking In the medical specialties, Geriatrics, Cardiology, Heart and Vascular Surgery, Cancer, and Diabetes & Endocrinology ranked as High Performing. Jefferson Moss-Magee Rehabilitation MossRehab Eight in the United States for MossRehab First in Pennsylvania In addition to specialty rankings, U.S. News & World Report rates hospitals for procedures and conditions. Below are some highlights of the 2024-2025 ranking: Thomas Jefferson University Hospitals Abdominal Aortic Aneurysm Repair improved to High Performing from average in the Heart and Vascular group. Back Surgery (Spinal Fusion) improved from average in the Orthopedics group. High Performing in the following procedures/conditions: Heart Bypass Surgery, Heart Attack, Congestive Heart Failure, Hip Replacement, Knee Replacement, Hip Fracture, Colon Cancer Surgery, Gynecological Cancer Surgery, Lung Cancer Surgery, Prostate Cancer Surgery, Leukemia, Lymphoma, & Myeloma, Chronic Obstructive Pulmonary Disease, Pneumonia, Stroke, Diabetes, and Kidney Failure. Jefferson Abington Hospital High Performing in the following procedures/conditions: Congestive Heart Failure, Hip Replacement, Knee Replacement, Colon Cancer Surgery, Lung Cancer Surgery, Leukemia, Lymphoma, & Myeloma, Chronic Obstructive Pulmonary Disease, Pneumonia, Stroke, Diabetes and Kidney Failure. Jefferson Health New Jersey (Jefferson Cherry Hill Hospital, Jefferson Stratford Hospital, Jefferson Washington Township Hospital) High Performing in the following procedures/conditions: Congestive Heart Failure, Hip Replacement, Knee Replacement, Leukemia, Lymphoma, & Myeloma, Chronic Obstructive Pulmonary Disease, Pneumonia, and Kidney Failure. Jefferson Health Northeast (Jefferson Bucks Hospital, Jefferson Torresdale Hospital and Jefferson Frankford Hospital) High Performing in the following procedures/conditions: Congestive Heart Failure, Knee Replacement, Chronic Obstructive Pulmonary Disease, Pneumonia. Jefferson Einstein Philadelphia Hospital High Performing in the following procedures/conditions: Congestive Heart Failure and Kidney Failure. Jefferson Lansdale Hospital High Performing in the following procedures/conditions: Knee Replacement and Hip Replacement. Best Regional Hospital Awards for Equitable Access Jefferson Health's three New Jersey Hospitals – based in Cherry Hill, Stratford and Washington Township – have been recognized by U.S. News & World Report for their success in caring for patients in historically underserved communities. The inaugural "Best Regional Hospital Awards for Equitable Access" honors community hospitals' dedication to equitable access. Jefferson's NJ hospitals have formal programs in place to address health disparities, including providing language access for those with limited English proficiency and services for community members with health-related social needs. U.S. News & World Report's analysis of all current Best Regional Hospitals in the U.S. identified 53 hospitals in 26 states achieving excellent outcomes among disadvantaged communities. These hospitals are recognized for providing certain vulnerable populations with substantial access to high-quality care. About Jefferson  Nationally ranked, Jefferson, which is principally located in the greater Philadelphia region and southern New Jersey, is reimagining health care and higher education to create unparalleled value. Jefferson is more than 42,000 people strong, dedicated to providing the highest-quality, compassionate clinical care for patients; making our communities healthier and stronger; preparing tomorrow's professional leaders for 21st-century careers; and creating new knowledge through basic/programmatic, clinical and applied research. Thomas Jefferson University, home of Sidney Kimmel Medical College, Jefferson College of Nursing, and the Kanbar College of Design, Engineering and Commerce, dates back to 1824 and today comprises 10 colleges and three schools offering 200+ undergraduate and graduate programs to more than 8,300 students. Jefferson Health, nationally ranked as one of the top healthcare systems in the country and the largest provider in the Philadelphia area, serves patients through millions of encounters each year at 17 hospitals and more than 160 outpatient and urgent care locations throughout the region. Jefferson Health Plans is a not-for-profit managed health care organization providing a broad range of health coverage options in Pennsylvania and New Jersey for more than 35 years. SOURCE Jefferson

WESTBOROUGH, Mass.--( BUSINESS WIRE )-- Miach Orthopaedics , Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue restoration, today announced initiation of the Bridge Registry Post-Market Study of the company’s Bridge-Enhanced ACL Restoration (BEAR®) Implant for anterior cruciate ligament (ACL) tears. The Bridge Registry ( NCT05398341 ) will assess real-world evidence of the BEAR Implant, with approval to enroll up to 750 patients at up to 30 sites in the U.S. Primary outcomes being tracked include knee function and feeling measured by International Knee Documentation Committee (IKDC) Subjective Knee Evaluation at two years and knee laxity measured with Lachman scoring at one year. “Our orthopedic sports medicine team at Rothman Orthopaedics Florida and AdventHealth are thrilled to offer our adult and pediatric patients the most innovative technologies to optimize patient recovery and performance after ACL injury,” said Dr. Daryl C. Osbahr, chief of orthopedic surgery at AdventHealth’s Rothman Orthopaedic Institute and co-lead principal investigator for the study. “The BEAR procedure and Bridge Registry enable our team to provide cutting edge techniques to our patients while also being focused on conducting research with the goal of continually refining our techniques based on evidence-based outcomes.” The BEAR Implant serves as a bridge to restore the patient’s own ACL and is the first medical technology that has been clinically proven to enable healing of a torn ACL. It is a paradigm shift from the current standard of care – reconstruction that replaces the ACL with a graft. The BEAR Implant acts as a bridge to help the torn ends of the ACL heal together. It is designed to hold and protect the patient’s own blood in the gap between the ACL ends to allow the formation of a clot, which is necessary for healing. “As we are now just over a year since our very first BEAR procedure, we continue to be impressed with the results,” said Dr. Sabrina Strickland, orthopedic surgeon at Hospital for Special Surgery and co-lead principal investigator for the study. “I look forward to being a part of the Bridge Registry, as careful follow-up of the outcomes of surgery allows us to accurately assess surgical techniques.” Leading academic institutions currently recruiting patients include the following: AdventHealth (Florida) – Site PI: Dr. Sean Keyes “The BEAR Implant is changing the way we manage young patients with ACL injuries. Talking about the BEAR Implant to my patients, and their parents, has turned into talking about the long-term health of their knee.” Duke University (North Carolina) – Site PI: Dr. Brian Lau “The BEAR Implant is a game changer for ACL surgery, and we are impressed with the early results. We are excited to be part of the Bridge Registry to follow our patients to continue to improve this new surgical technique.” Hospital for Special Surgery (New York) – Site PI: Dr. Sabrina Strickland The following institutions will begin enrolling patients soon: Boston Children’s Hospital (Massachusetts) – Site PI: Dr. Dennis Kramer Ochsner Health System (Louisiana) – Site PI: Dr. Jeremy Burnham Stanford University School of Medicine (California) – Site PI: Dr. Seth Sherman Steamboat Orthopaedic & Spine Institute (Colorado) – Site PI: Dr. Alex Meininger Victory Sports Medicine / Auburn Community Hospital (New York) – Site PI: Dr. Marc Pietropaoli Virtua Health (New Jersey) – Site PI: Dr. Sean McMillan “The Bridge Registry provides evidence to supplement the extensive base of clinical trial research that has been conducted on the BEAR Implant over the last few decades,” said Patrick McBrayer, president and CEO, Miach Orthopaedics. “The real-world evidence we collect through the registry will enable us to track key outcomes as the BEAR procedure is adapted for commercial use.” About The BEAR® Implant The Bridge-Enhanced ACL Restoration (BEAR ® ) Implant is a proprietary bio-engineered implant used to facilitate healing of the torn ACL. The BEAR Implant is the first medical technology to demonstrate, with Level 1 clinical evidence, that it enables the body to heal its own torn ACL. Unlike reconstruction, which is the current standard of care, the BEAR Implant does not require a second surgical wound site to remove a healthy tendon from another part of the leg or the use of a donor tendon. The BEAR Implant acts as a bridge between the two ends of the torn ACL. The surgeon injects a small amount of the patient’s own blood into the implant and inserts it between the torn ends of the ACL in a minimally invasive procedure. The combination of the BEAR Implant and the patient’s blood enables the body to heal the torn ends of the ACL back together while maintaining the ACL’s original attachments to the femur and tibia. The BEAR Implant is resorbed by the body as the ACL heals. The BEAR Implant was granted De Novo Approval from the U.S. Food and Drug Administration in December 2020. It is indicated for skeletally mature patients at least 14 years of age with a complete rupture of the ACL, as confirmed by MRI. Patients must have an ACL stump attached to the tibia to facilitate the restoration. Visit miachortho.com for complete product information, including Instructions for Use. About Miach Orthopaedics, Inc. Miach Orthopaedics , Inc., is a privately held company located in Westborough, Massachusetts, dedicated to developing bio-engineered surgical implants for connective tissue restoration. The company’s initial focus is the BEAR® Implant, which represents a paradigm shift in the treatment of ACL tears from reconstruction to restoration. For more information on Miach Orthopaedics and its products, visit www.miachortho.com and follow the company on Facebook , Instagram , Twitter and LinkedIn .

ORANGE, Calif. and ROCKLIN, Calif., Sept. 1, 2022 /PRNewswire/ -- Luna, the leading in-home physical therapy (PT) platform, today announces the launch of a value-based savings program for orthopaedic practices to reduce post-acute care costs by 55-70%. Top orthopaedic groups are turning to Luna to reduce costs and deliver this innovative, in-person form of care, including Hoag (Orange County), Resurgens Orthopaedics (Atlanta), and dozens of others. While hospital-at-home continues to shake up healthcare, the latest rapid-growth sector is outpatient PT-at-home - a more cost effective approach over traditional home health, which consists of the same high quality PT services that patients typically receive at a clinic - delivered in the comfort of their own home. A recent study showed that Luna's outpatient in-home PT saves an average of $3,000 per case for post-surgical rehab for bundled care cases, equating to Medicare savings of 55%-70% per case. "These significant savings demonstrate why Luna is the future of healthcare," said Mike West, former CEO of Rothman Orthopaedic Institute. "For orthopaedic surgeons, the rehabilitation experience should act as an extension of your practice, but that kind of compliance isn't always easy to come by. With Luna, surgeons and orthopedic groups can ensure that patients receive the highest quality care and make meaningful progress." "Orthopaedic surgeons are turning to Luna for a cost effective post-surgical PT-at-home experience for their patients, without compromising quality," said Palak Shah, Luna co-founder and head of clinical operations. "We are committed to an innovative, tech-enabled approach to rehabilitation. Our superior data, algorithms, and technology, together with our team of exceptional therapists, deliver a high quality, precision experience for post-surgical care with faster recoveries - and is 55-70% less than the average cost of home health." Luna works with orthopaedic surgeons and their teams to identify and set protocols, care pathways, and escalation triggers. Depending on the surgeon and the type of surgery performed, Luna technology automatically assigns specific protocols or care pathways to patients. Physical therapists have a seamless way to access this information and track progress in real-time with phase-specific escalation questions via the Luna app. All of this is shared with the surgeon's team to ensure the highest standards of care. Luna operates in 43 U.S. markets and 24 states. To date, Luna has partnered with innovative health systems, including Emory Health, SCL Health, UCLA Health, and Scripps Health, to activate outpatient in-home physical therapy for their patient communities. SOURCE Luna